Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Tillomed Laboratories Ltd, 220 Butterfield, Great Marlings, Luton, LU2 8DL
Half Beta – Prograne 80mg Sustained Release Capsules.
| Pharmaceutical Form |
|---|
|
Sustained Release Capsule. Size 3 capsules with opaque white caps and colourless transparent bodies filled with regular creamy white microgranules. |
Each capsule contains 80 mg of propranolol hydrochloride.
Excipients with known effect: The capsule contains Neutral micogrananules (sugar-starch) and Sulfur Dioxide (E220).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Propranolol |
Propranolol is a competitive antagonist at both beta, and beta2-adrenoceptor, but has membrane stabilising activity at concentrations exceeding 1-3mg/litre, though such concentrations are rarely achieved during oral therapy. Competitive beta-blockade has been demonstrated in man by a parallel shift to the right in the dose-heart rate response curve to beta-agonists such as isoprenaline. |
| List of Excipients |
|---|
|
Neutral microgranules |
Blister packs:
PVC: Colourless 250 micron thickness
Aluminium: 25 microns thickness
28 capsules per pack, 14 capsules per blister strip.
Not all packs sizes may be marketed.
Tillomed Laboratories Ltd, 220 Butterfield, Great Marlings, Luton, LU2 8DL
PL 11311/0017
25/02/2009
| Drug | Countries | |
|---|---|---|
| BETA-PROGRANE | Ireland, United Kingdom | |
| HALF BETA-PROGRANE | Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
